Add-on Intravenous Immunoglobulins in Early Myositis

NCT05832034 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Myopathy, Idiopathic
Dermatomyositis
Antisynthetase Syndrome
Immune-Mediated Necrotizing Myopathy
Polymyositis
Myositis

Interventions

DRUG: Immune Globulin Intravenous (Human)
DRUG: Placebo

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]
[object Object]